Symptomatic brain metastases in melanoma.
Exp Dermatol
; 33(4): e15075, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38610093
ABSTRACT
Although clinical outcomes in metastatic melanoma have improved in recent years, the morbidity and mortality of symptomatic brain metastases remain challenging. Response rates and survival outcomes of patients with symptomatic melanoma brain metastases (MBM) are significantly inferior to patients with asymptomatic disease. This review focusses upon the specific challenges associated with the management of symptomatic MBM, discussing current treatment paradigms, obstacles to improving clinical outcomes and directions for future research.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Exp Dermatol
Journal subject:
DERMATOLOGIA
Year:
2024
Type:
Article
Affiliation country:
Australia